South Korean Biopharma companies GC Cell and GC Lab Cell are merging in an all-stock Deal. The companies have a combined market cap of ~US$1.5bn. The Deal is expected to complete in 4Q 2021.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.